Targeting LAMC1: Small Molecules, Antibodies and CRISPR/Cas9 (G3915)

Target Name: LAMC1

NCBI ID: G3915

LAMC1

Targeting LAMC1: Small Molecules, Antibodies and CRISPR/Cas9

LAMC1 (LAMC1_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. It is a member of the LAMINARIES family of proteins, which are known for their role in cell-cell adhesion and tissue organization.

LAMC1 is involved in many different cellular processes in the body, including cell signaling, migration, and invasion. It has been shown to play a role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Due to its involvement in so many cellular processes, LAMC1 has been identified as a potential drug target or biomarker. Researchers are exploring the use of small molecules, antibodies, and other therapeutic approaches to target LAMC1 and its activity.

One approach to targeting LAMC1 is through the use of small molecules, which can interact with the protein and alter its function. Researchers have identified a number of small molecules that have been shown to interact with LAMC1 and have the potential to be used as drug candidates. These molecules include inhibitors of protein-protein interactions, modulators of protein stability, and inhibitors of DNA replication.

Another approach to targeting LAMC1 is through the use of antibodies, which can recognize and bind to the protein and prevent it from functioning. Researchers have developed antibodies that are specific for LAMC1 and have shown promise in preclinical studies for targeting the protein in various tissues.

In addition to small molecules and antibodies, researchers are also exploring the use of other therapeutic approaches to target LAMC1. These include genetic modifiers, such as CRISPR/Cas9 technology, which can be used to alter the expression of LAMC1 and other genes.

Overall, LAMC1 is a protein that is involved in many important cellular processes in the human body. As a potential drug target or biomarker, LAMC1 is an attractive target for researchers to explore in order to develop new treatments for a variety of diseases.

Protein Name: Laminin Subunit Gamma 1

Functions: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components

The "LAMC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LAMC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets